Tata Chemicals reported Q1FY27 consolidated revenue of ₹4,255 Crore and EBITDA of ₹555 Crore. The results reflect challenging industrial demand and lower realizations in overseas markets.
Tata Chemicals Limited reported Q4FY26 consolidated revenue of ₹3,438 Crore and EBITDA of ₹274 Crore. The Board recommended an ₹11 per share dividend and approved a ₹100 Crore investment to expand salt capacity at Mithapur. Performance was impacted by global pricing pressure and a ₹1,837 Crore goodwill impairment in its US operations.